ITGAV and melanoma: Here we establish that TXNIP silencing in human melanoma cells—to an extent commensurate with the decrease observed in malignant versus benign lesions in patients—did not affect melanoma cell proliferation nor ROS levels but affected the expression of proteins of particular relevance to melanoma cell invasiveness, integrin alpha-v/beta-3 and TIMP-2.